Fundz

Alpheus Medical raised $52M in Series B funding led by HealthQuest Capital and Samsara BioCapital to support a Phase 2B trial for glioblastoma treatment.

PRIVATEMay 15, 2025

Amount Raised

$52 Million

Round Type

Series B

ChanhassenOtherHealthcare

Investors

Brain Tumor Investment FundOrbimedBrightEdgeHealthQuest CapitalSamsara BiocapitalSontag Innovation FundAction Potential Venture Capita

Description

Alpheus Medical, a Chanhassen, MN-based clinical-stage oncology company, raised $52M in Series B funding. The round was led by HealthQuest Capital and Samsara BioCapital. The funds will support a Phase 2B trial for glioblastoma treatment. This innovative therapy selectively targets and destroys cancer cells using ultrasound.

Quick answer

Alpheus Medical raised $52 Million in a Series B round, dated May 15, 2025. Investors: Brain Tumor Investment Fund, Orbimed, BrightEdge, HealthQuest Capital, Samsara Biocapital, Sontag Innovation Fund and Action Potential Venture Capita. Alpheus Medical is based in Chanhassen, Minnesota, United States.

How much did Alpheus Medical raise?
Alpheus Medical raised $52 Million in a Series B round on May 15, 2025.
Who invested in Alpheus Medical?
Brain Tumor Investment Fund, Orbimed, BrightEdge, HealthQuest Capital, Samsara Biocapital, Sontag Innovation Fund and Action Potential Venture Capita are named as investors in this round.
What does Alpheus Medical do?
Alpheus Medical, Inc, is a privately held company based in Oakdale, Minnesota, developing a novel sonodynamic therapy platform targeting solid body cancers.
Where is Alpheus Medical based and how big is it?
Alpheus Medical is based in Chanhassen, Minnesota, United States. Fundz records about 11 employees.
Who are the decision-makers at Alpheus Medical?
Fundz holds 3 contacts at Alpheus Medical, including the Chief Financial Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as Alpheus Medical that raised within 45 days of this round, from Fundz verified event records.

  • Biofrontera raised $11M on June 27, 2025.
  • NewcelX raised $1M (Seed) on June 27, 2025.
  • Actuate Therapeutics raised $4.7M (Seed) on June 27, 2025.
  • Armis Biopharma raised $1M (Seed) on June 27, 2025.
  • Zyus raised $500K (Post-IPO Equity) on June 27, 2025.
  • Artelo Biosciences raised $1.4M (Seed) on June 26, 2025.

Who to call at Alpheus Medical, and when

A new round usually means Alpheus Medical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Alpheus Medical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Alpheus Medical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Alpheus Medical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Alpheus Medical

Location

1266 Park Road

Chanhassen, Minnesota, United States

About

Alpheus Medical, Inc, is a privately held company based in Oakdale, Minnesota, developing a novel sonodynamic therapy platform targeting solid body cancers. The company’s lead product utilizes a novel, non-invasive drug device combination for outpatient treatment of recurrent glioblastoma multiforme (rGBM). Alpheus Medical’s work has been developed in conjunction with some of the most accomplished names worldwide in neuro-oncology, and with support from the American Cancer Society and National Brain Tumor Society.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Alpheus Medical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsImran, Chief Financial Officer hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Alpheus Medical's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Alpheus Medical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.